3 Stocks Underperforming Today In The Health Services Industry

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 23 points (-0.2%) at 15,060 as of Friday, May 10, 2013, 12:49 PM ET. The NYSE advances/declines ratio sits at 1,550 issues advancing vs. 1,371 declining with 121 unchanged.

The Health Services industry currently sits up 0.6% versus the S&P 500, which is unchanged. On the negative front, top decliners within the industry include Grifols ( GRFS), down 3.28, and Intuitive Surgical ( ISRG), down 2.41. Top gainers within the industry include Unilife Corporation ( UNIS), up 58.4%, St Jude Medical ( STJ), up 1.9%, Edwards Life ( EW), up 1.5%, Boston Scientific ( BSX), up 1.4% and HCA Holdings ( HCA), up 1.5%.

TheStreet Ratings group would like to highlight 3 stocks pushing the industry lower today:

3. Sirona Dental Systems ( SIRO) is one of the companies pushing the Health Services industry lower today. As of noon trading, Sirona Dental Systems is down $4.01 (-5.3%) to $71.40 on heavy volume Thus far, 474,357 shares of Sirona Dental Systems exchanged hands as compared to its average daily volume of 245,900 shares. The stock has ranged in price between $71.13-$75.40 after having opened the day at $75.27 as compared to the previous trading day's close of $75.41.

Sirona Dental Systems, Inc., together with its subsidiaries, develops, manufactures, and markets dental equipment for dentists worldwide. It operates in four segments: Dental CAD/CAM Systems, Imaging Systems, Treatment Centers, and Instruments. Sirona Dental Systems has a market cap of $4.3 billion and is part of the health care sector. The company has a P/E ratio of 31.8, above the S&P 500 P/E ratio of 17.7. Shares are up 16.8% year to date as of the close of trading on Thursday.

TheStreet Ratings rates Sirona Dental Systems as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income, good cash flow from operations and growth in earnings per share. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Sirona Dental Systems Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

2. As of noon trading, CareFusion ( CFN) is down $1.34 (-3.9%) to $33.31 on heavy volume Thus far, 3.1 million shares of CareFusion exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $32.48-$33.91 after having opened the day at $33.91 as compared to the previous trading day's close of $34.65.

CareFusion Corporation provides various healthcare products and services in the United States and internationally. It operates in two segments, Medical Systems and Procedural Solutions. CareFusion has a market cap of $7.7 billion and is part of the health care sector. Shares are up 21.1% year to date as of the close of trading on Thursday.

TheStreet Ratings rates CareFusion as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and increase in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full CareFusion Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

1. As of noon trading, Aetna ( AET) is down $0.47 (-0.8%) to $59.02 on average volume Thus far, 1.5 million shares of Aetna exchanged hands as compared to its average daily volume of 3.4 million shares. The stock has ranged in price between $58.88-$59.71 after having opened the day at $59.43 as compared to the previous trading day's close of $59.49.

Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $19.3 billion and is part of the health care sector. The company has a P/E ratio of 12.2, below the S&P 500 P/E ratio of 17.7. Shares are up 28.5% year to date as of the close of trading on Thursday.

TheStreet Ratings rates Aetna as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, attractive valuation levels, largely solid financial position with reasonable debt levels by most measures and growth in earnings per share. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Aetna Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

A reminder about TheStreet Ratings group: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

null

More from Markets

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

Aceto's Search for Deal May Be Slowed by DOJ Subpoena

Aceto's Search for Deal May Be Slowed by DOJ Subpoena

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists